Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study.
Pimenta MC, Torres TS, Hoagland B, Cohen M, Mann CG, Jalil CM, Carvalheira E, Freitas L, Fernandes N, Castanheira D, Benedetti M, Moreira J, Simpson K, Trefiglio R, O'Malley G, Veloso VG, Grinsztejn B. Pimenta MC, et al. Among authors: o malley g. JMIR Public Health Surveill. 2024 Oct 24;10:e60961. doi: 10.2196/60961. JMIR Public Health Surveill. 2024. PMID: 39446416 Free PMC article.
Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study.
Grinsztejn B, Torres TS, Hoagland B, Jalil EM, Moreira RI, O'Malley G, Shade SB, Benedetti MR, Moreira J, Simpson K, Pimenta MC, Veloso VG; ImPrEP CAB-Brasil Study Team. Grinsztejn B, et al. JMIR Public Health Surveill. 2023 Apr 19;9:e44961. doi: 10.2196/44961. JMIR Public Health Surveill. 2023. PMID: 37074775 Free PMC article.
Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
Roche SD, Barnabee G, Omollo V, Mogaka F, Odoyo J, Bukusi EA, Morton JF, Johnson R, Celum C, Baeten JM, O'Malley G. Roche SD, et al. BMC Health Serv Res. 2022 Mar 30;22(1):422. doi: 10.1186/s12913-022-07742-8. BMC Health Serv Res. 2022. PMID: 35354456 Free PMC article. Clinical Trial.
Provider-client rapport in pre-exposure prophylaxis delivery: a qualitative analysis of provider and client experiences of an implementation science project in Kenya.
Omollo V, Roche SD, Mogaka F, Odoyo J, Barnabee G, Bukusi EA, Katz AWK, Morton J, Johnson R, Baeten JM, Celum C, O'Malley G. Omollo V, et al. Sex Reprod Health Matters. 2022 Dec;30(1):2095707. doi: 10.1080/26410397.2022.2095707. Sex Reprod Health Matters. 2022. PMID: 36169648 Free PMC article.
Brief Report: "What Is This PrEP?"-Sources and Accuracy of HIV Pre-Exposure Prophylaxis (PrEP) Awareness Among Adolescent Girls and Young Women Attending Family Planning and Maternal Child Health Clinics in Western Kenya.
Dettinger JC, Pintye J, Dollah A, Awuor M, Abuna F, Lagat H, Kohler P, John-Stewart G, O'Malley G, Kinuthia J, Beima-Sofie K. Dettinger JC, et al. J Acquir Immune Defic Syndr. 2021 Dec 1;88(4):356-360. doi: 10.1097/QAI.0000000000002782. J Acquir Immune Defic Syndr. 2021. PMID: 34379606 Free PMC article.
Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial.
Irungu EM, Mugwanya KK, Mugo NR, Bukusi EA, Donnell D, Odoyo J, Wamoni E, Peacock S, Morton JF, Ngure K, Mugambi M, Mukui I, O'Malley G, Baeten JM; Partners Scale-Up Project Team. Irungu EM, et al. Lancet Glob Health. 2021 Dec;9(12):e1730-e1739. doi: 10.1016/S2214-109X(21)00391-0. Lancet Glob Health. 2021. PMID: 34798031 Free PMC article. Clinical Trial.
284 results